Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...

At the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, especially ...

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, ...

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...

Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...

In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss ...

A practitioner has explained the 'two problems' that may come with taking proton pump inhibitors (PPI), such as omeprazole, for a long time. Specialist, Simon Mills, shared the potential issues on an ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple ...

Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

Dr. Nishtha Sareen, medical director of the Ascension Saint Thomas Women's Heart Program, offered free heart screenings to ...